rct
    2009

    Effect of Ginkgo biloba versus nifedipine on the frequency of Raynaud attacks: a randomized trial

    Choi WS, Choi CJ, Kim KS

    Published in Journal of Clinical Pharmacy and Therapeutics

    Methodology

    Randomised open comparison of Ginkgo biloba extract with nifedipine over 8 weeks in primary Raynaud phenomenon.

    Key Findings

    Both treatments reduced attack frequency, with nifedipine producing a greater reduction than Ginkgo biloba.

    Conclusions

    Ginkgo is inferior to standard vasodilator therapy for cold-induced attacks.

    Limitations

    Small, unblinded, no placebo arm.

    Supplements Studied

    Both treatments reduced attack frequency, with nifedipine producing a greater reduction than Ginkgo biloba.

    Related Health Concerns

    Study Details

    Year:2009
    Sample Size:40
    Quality Score:6/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.